Екатеринбургский медицинский научный центр профилактики и охраны здоровья рабочих промпредприятий Роспотребнадзора, Екатеринбург, Россия
Пятигорский медико-фармацевтический институт – филиал Волгоградского государственного медицинского университета Минздрава России, Пятигорск, Россия
INTRODUCTION. The beneficial effect of the ozone therapy use in acute serous gestational pyelonephritis is well-known. However, in the scientific literature there is no information on the effect of medical ozone on the functional state of placental fetal blood flow with this pathology. AIM. To study the dynamics of fetoplacental complex parameters in women suffering from acute serous gestational pyelonephritis using ozone-oxygen mixture. MATERIAL AND METHODS. The studies were conducted on 93 pregnant women at the age of 28 (16-39) years old suffering from acute serous gestational pyelonephritis, gestational age was from 14 to 26 weeks, who were randomized into two groups: the first/study (n=46) group and the second/control (n=47) one. The control group of pregnant women took only the drug standard according to the Federal Clinical Guidelines. In the study group, drug therapy was supplemented by intravenous administration of an ozone-oxygen mixture. Both groups were evaluated in the dynamics of ultrasound examination of the fetoplacental complex, as well as uterine and placental blood flow Dopplerometry. DISCUSSION. The increase in the effectiveness of restorative treatment of women with acute serous gestational pyelonephritis including ozone therapy is due to an increase in the initially reduced diastolic blood perfusion rate; summation of the therapeutic effects of ozone and pharmacotherapy; enhancement of pharmacopotential value of the used medicinal preparation. CONCLUSION. Parenteral application of ozone-oxygen mixture in programs of restorative treatment of women with acute serous gestational pyelonephritis provides significant improvement of functional state of placental-uterine blood flow.
serous, acute gestational pyelonephritis, ozone therapy, pregnancy complications
1. Shkodkin S.V. Gestacionnyy pielonefrit: s chego nachat'? Vestnik urologii. 2019; 7 (3): 41-46. https://doi.org/10.21886/2308-6424-2019-7-3-41-46
2. Cunningham F.G., Lucas M.J. Urinary tract infections complicating pregnancy. Baillière's Clinical Obstetrics and Gynaecology. 1994; (8): 353-373. https://doi.org/10.1016/s0950-3552(05)80325-6
3. Kozak Yu.V., Kiseleva T.V., Pekarev O.G., Pozdnyakov I.M. Primenenie ekstrakorporal'nyh metodov detoksikacii pri lechenii beremennyh s ostrymi gestacionnymi pielonefritami. Medicina i obrazovanie v Sibiri. 2012; (1).
4. Şimşir A., Kızılay F., Semerci B. Comparison of percutaneous nephrostomy and double J stent in symptomatic pregnancy hydronephrosis treatment. Turkish Journal of Medical Sciences. 2018; 48(2): 405-411. https://doi.org/10.3906/sag-1711-5
5. Lokshin K.L. Drenirovanie verhnih mochevyh putey pri ostrom pielonefrite u beremennyh: Zachem? Komu? Kak dolgo? Vestnik urologii. 2019; 7(3): 35-40. https://doi.org/10.21886/2308-6424-2019-7-3-35-40
6. Wang T., Wu G., Wang J., Cui Y., Ma J. et al. Comparison of Single-dose Fosfomycin Tromethamine and Other Antibiotics for Lower Uncomplicated Urinary Tract Infection in Women and Asymptomatic Bacteriuria in Pregnant Women: a systematic review and meta-analysis. International Journal of Antimicrobial Agents. 2020; 56 (1): 106018. https://doi.org/10.1016/j.ijantimicag.2020.106018
7. Asmat U., Mumtaz M. Z., Malik A. Rising prevalence of multidrug-resistant uropathogenic bacteria from urinary tract infections in pregnant women. Journal of Taibah University Medical Sciences. 2020: 16(1): 102-111. https://doi.org/10.1016/j.jtumed.2020.10.010
8. 8. Plehanov A.A., Hvorostuhina N.F., Stepanova N.N., Satueva E.Ya., Mamedova M.M. Vliyanie gestacionnogo pielonefrita na techenie i ishod beremennosti. Sovremennye problemy nauki i obrazovaniya. 2018; (4): 128 c.
9. Satueva E.Ya., Mamedova M.M. Ostryy gestacionnyy pielonefrit i ego vliyanie na techenie i ishod beremennosti. Byulleten' medicinskih Internet-konferenciy. 2018; 8(5): 192-193.
10. Hardikov A.V., Petrov S.V., Lyadvin A.Yu. Svyaz' placentarno-plodovogo krovotoka s yadernym indeksom intoksikacii pri neoslozhnennom pielonefrite u beremennyh. Medicina. 2016; 3(15): 40-44.
11. Naboka Yu.L., Rymashevskiy A.N., Kogan O.M., Gudima I.A., Vorob'eva N.V., Al'kina A.K. Bessimptomnaya bakteriuriya i pielonefrit pri beremennosti. Medicinskiy vestnik Yuga Rossii. 2021; 12(3): 22-31. https://doi.org/10.21886/2219-8075-2021-12-3-22-31
12. Zhigunova A.K. Primenenie uroantiseptikov pri lechenii zabolevaniy mochevydelitel'noy sistemy v period beremennosti. Zdorov'e zhenschin. 2014; 1(93): 72-78.
13. Huraseva A.B., Petrov S.V. Fitoprofilaktika infekcionnyh oslozhneniy gestacii u zhenschin s hronicheskim pielonefritom. Medicinskiy alfa- vit. 2019; 1(1): 76-79. https://doi.org/10.33667/2078-5631-2019-1-1(376)-76-79
14. Grette K., Cassity S., Holliday N., Rimawi B.H. Acute pyelonephritis during pregnancy: a systematic review of the aetiology, timing, and reported adverse perinatal risks during pregnancy. Journal of Obstetrics and Gynaecology. 2020; 40(6): 739-748. https://doi.org/10.1080/01443615.2019.1647524
15. Ponomarenko G.N. Fizicheskaya i reabilitacionnaya medicina: nacional'noe rukovodstvo. Moskva. GEOTAR-Media. 2020: 688 s.
16. Kastueva N.D., Callagova L.V., Merdenova L.A., Maysuradze L.V. Rol' novyh medicinskih tehnologiy v akusherstve i ginekologii. Sovremennye voprosy biomediciny. 2018; 2(3): 132-145.
17. Fedorova T.A., Mihaylova O.I., Tyutyunnik V.L., Bakuridze E.M., Vinogradova M.A. Opyt primeneniya medicinskogo ozona v kompleksnoy terapii placentarnoy nedostatochnosti. Bioradikaly i Antioksidanty. 2016; 3(3): 176-179.
18. Gaitova M.R., Fedorov A.A., Frank M.A. Effektivnost' kompleksnogo lecheniya s vklyucheniem ozonoterapii ostrogo gestacionnogo pielonefrita. Kurortnaya medicina. 2021; (1): 54-59.
